NYSE:XAN - Exantas Capital Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$10.57 +0.07 (+0.67 %)
(As of 03/25/2019 01:41 PM ET)
Previous Close$10.50
Today's Range$10.44 - $10.61
52-Week Range$9.26 - $12.09
Volume31,549 shs
Average Volume156,384 shs
Market Capitalization$336.65 million
P/E Ratio14.89
Dividend Yield6.67%
Exantas Capital Corp. engages in the provision of real estate finance services. It focuses on originating, holding and managing commercial mortgage loans, and commercial real estate-related debt investments. The company was founded in 2005 and is headquartered in New York, NY.

Receive XAN News and Ratings via Email

Sign-up to receive the latest news and ratings for XAN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Real estate investment trusts



Sales & Book Value

Annual Sales$55.28 million
Cash Flow$0.8890 per share
Book Value$17.49 per share


Net Income$27.43 million


Market Cap$336.65 million
Next Earnings Date5/2/2019 (Estimated)

Exantas Capital (NYSE:XAN) Frequently Asked Questions

What is Exantas Capital's stock symbol?

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

How often does Exantas Capital pay dividends? What is the dividend yield for Exantas Capital?

Exantas Capital declared a quarterly dividend on Monday, March 18th. Stockholders of record on Friday, March 29th will be given a dividend of $0.20 per share on Friday, April 26th. This represents a $0.80 annualized dividend and a dividend yield of 7.58%. The ex-dividend date is Thursday, March 28th. This is a boost from Exantas Capital's previous quarterly dividend of $0.18. View Exantas Capital's Dividend History.

How were Exantas Capital's earnings last quarter?

Exantas Capital Corp (NYSE:XAN) released its quarterly earnings results on Tuesday, March, 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.23 by $0.01. The company had revenue of $15.58 million for the quarter, compared to the consensus estimate of $14.70 million. Exantas Capital had a net margin of 49.61% and a return on equity of 2.75%. View Exantas Capital's Earnings History.

When is Exantas Capital's next earnings date?

Exantas Capital is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Exantas Capital.

What price target have analysts set for XAN?

3 analysts have issued 12-month price targets for Exantas Capital's stock. Their forecasts range from $12.00 to $13.00. On average, they expect Exantas Capital's stock price to reach $12.50 in the next year. This suggests a possible upside of 18.4% from the stock's current price. View Analyst Price Targets for Exantas Capital.

What is the consensus analysts' recommendation for Exantas Capital?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exantas Capital.

Has Exantas Capital been receiving favorable news coverage?

News coverage about XAN stock has trended positive on Monday, according to InfoTrie. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Exantas Capital earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.

Who are some of Exantas Capital's key competitors?

What other stocks do shareholders of Exantas Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exantas Capital investors own include Enterprise Products Partners (EPD), CHIMERA INVT CO/SH NEW (CIM), Hercules Capital (HTGC), DIGITAL RLTY TR/SH (DLR), Enbridge (ENB), JD.Com (JD), CyrusOne (CONE), Welltower (WELL), Micron Technology (MU) and New Residential Investment (NRZ).

Who are Exantas Capital's key executives?

Exantas Capital's management team includes the folowing people:
  • Robert C. Lieber, Chief Executive Officer
  • Matthew J. Stern, President
  • Thomas C. Elliott, Executive Vice President-Operations & Finance
  • David J. Bryant, Chief Financial Officer, Treasurer & Senior VP
  • Jeffrey Dean Blomstrom, Senior Vice President

Who are Exantas Capital's major shareholders?

Exantas Capital's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.66%), Acadian Asset Management LLC (3.34%), Bayview Asset Management LLC (2.67%), Ancora Advisors LLC (2.02%), Mackenzie Financial Corp (1.27%) and Northern Trust Corp (1.16%). View Institutional Ownership Trends for Exantas Capital.

Which major investors are selling Exantas Capital stock?

XAN stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Two Sigma Investments LP, GSA Capital Partners LLP, Two Sigma Advisers LP, Millennium Management LLC, BlackRock Inc., Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp and Northern Trust Corp. View Insider Buying and Selling for Exantas Capital.

Which major investors are buying Exantas Capital stock?

XAN stock was purchased by a variety of institutional investors in the last quarter, including Bayview Asset Management LLC, Mackenzie Financial Corp, Acadian Asset Management LLC, D. E. Shaw & Co. Inc., Summit Global Investments, Los Angeles Capital Management & Equity Research Inc., American Century Companies Inc. and SG Americas Securities LLC. View Insider Buying and Selling for Exantas Capital.

How do I buy shares of Exantas Capital?

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exantas Capital's stock price today?

One share of XAN stock can currently be purchased for approximately $10.56.

How big of a company is Exantas Capital?

Exantas Capital has a market capitalization of $336.34 million and generates $55.28 million in revenue each year. The company earns $27.43 million in net income (profit) each year or $0.71 on an earnings per share basis.

What is Exantas Capital's official website?

The official website for Exantas Capital is http://www.exantas.com.

How can I contact Exantas Capital?

Exantas Capital's mailing address is 717 FIFTH AVENUE, NEW YORK NY, 10022. The company can be reached via phone at 212-621-3210 or via email at [email protected]

MarketBeat Community Rating for Exantas Capital (NYSE XAN)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  44
MarketBeat's community ratings are surveys of what our community members think about Exantas Capital and other stocks. Vote "Outperform" if you believe XAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel